Mansur, A.; Song, P.N.; Lu, Y.; Burns, A.C.; Sligh, L.; Yang, E.S.; Sorace, A.G.
Combination Therapy with Trastuzumab and Niraparib: Quantifying Early Proliferative Alterations in HER2+ Breast Cancer Models. Biomedicines 2023, 11, 2090.
https://doi.org/10.3390/biomedicines11082090
AMA Style
Mansur A, Song PN, Lu Y, Burns AC, Sligh L, Yang ES, Sorace AG.
Combination Therapy with Trastuzumab and Niraparib: Quantifying Early Proliferative Alterations in HER2+ Breast Cancer Models. Biomedicines. 2023; 11(8):2090.
https://doi.org/10.3390/biomedicines11082090
Chicago/Turabian Style
Mansur, Ameer, Patrick N. Song, Yun Lu, Andrew C. Burns, Luke Sligh, Eddy S. Yang, and Anna G. Sorace.
2023. "Combination Therapy with Trastuzumab and Niraparib: Quantifying Early Proliferative Alterations in HER2+ Breast Cancer Models" Biomedicines 11, no. 8: 2090.
https://doi.org/10.3390/biomedicines11082090
APA Style
Mansur, A., Song, P. N., Lu, Y., Burns, A. C., Sligh, L., Yang, E. S., & Sorace, A. G.
(2023). Combination Therapy with Trastuzumab and Niraparib: Quantifying Early Proliferative Alterations in HER2+ Breast Cancer Models. Biomedicines, 11(8), 2090.
https://doi.org/10.3390/biomedicines11082090